DBV Technologies (DBVT) Competitors $4.47 -0.26 (-5.50%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DBVT vs. ABVX, PRTC, KMDA, CYRX, ATXS, ALLO, AKBA, CDXC, TERN, and KODShould you be buying DBV Technologies stock or one of its competitors? The main competitors of DBV Technologies include ABIVAX Société Anonyme (ABVX), PureTech Health (PRTC), Kamada (KMDA), Cryoport (CYRX), Astria Therapeutics (ATXS), Allogene Therapeutics (ALLO), Akebia Therapeutics (AKBA), ChromaDex (CDXC), Terns Pharmaceuticals (TERN), and Kodiak Sciences (KOD). These companies are all part of the "pharmaceutical products" industry. DBV Technologies vs. ABIVAX Société Anonyme PureTech Health Kamada Cryoport Astria Therapeutics Allogene Therapeutics Akebia Therapeutics ChromaDex Terns Pharmaceuticals Kodiak Sciences ABIVAX Société Anonyme (NASDAQ:ABVX) and DBV Technologies (NASDAQ:DBVT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation, profitability and community ranking. Which has more risk & volatility, ABVX or DBVT? ABIVAX Société Anonyme has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, DBV Technologies has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Do insiders & institutionals have more ownership in ABVX or DBVT? 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. Comparatively, 71.7% of DBV Technologies shares are held by institutional investors. 1.9% of DBV Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is ABVX or DBVT more profitable? ABIVAX Société Anonyme has a net margin of 0.00% compared to DBV Technologies' net margin of -815.73%. ABIVAX Société Anonyme's return on equity of 0.00% beat DBV Technologies' return on equity.Company Net Margins Return on Equity Return on Assets ABIVAX Société AnonymeN/A N/A N/A DBV Technologies -815.73%-106.07%-76.17% Does the MarketBeat Community prefer ABVX or DBVT? DBV Technologies received 396 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. However, 81.82% of users gave ABIVAX Société Anonyme an outperform vote while only 55.03% of users gave DBV Technologies an outperform vote. CompanyUnderperformOutperformABIVAX Société AnonymeOutperform Votes981.82% Underperform Votes218.18%DBV TechnologiesOutperform Votes40555.03% Underperform Votes33144.97% Do analysts prefer ABVX or DBVT? ABIVAX Société Anonyme presently has a consensus target price of $38.67, indicating a potential upside of 527.71%. DBV Technologies has a consensus target price of $22.50, indicating a potential upside of 403.36%. Given ABIVAX Société Anonyme's higher probable upside, equities research analysts plainly believe ABIVAX Société Anonyme is more favorable than DBV Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABIVAX Société Anonyme 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00DBV Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, ABVX or DBVT? DBV Technologies has higher revenue and earnings than ABIVAX Société Anonyme. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABIVAX Société AnonymeN/AN/A-$159.90MN/AN/ADBV Technologies$15.73M5.85-$72.73M-$4.50-0.99 Does the media prefer ABVX or DBVT? In the previous week, ABIVAX Société Anonyme and ABIVAX Société Anonyme both had 4 articles in the media. DBV Technologies' average media sentiment score of 0.74 beat ABIVAX Société Anonyme's score of 0.68 indicating that DBV Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABIVAX Société Anonyme 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DBV Technologies 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryABIVAX Société Anonyme and DBV Technologies tied by winning 7 of the 14 factors compared between the two stocks. Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DBVT vs. The Competition Export to ExcelMetricDBV TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$102.23M$2.95B$5.23B$8.95BDividend YieldN/A1.94%5.13%4.04%P/E Ratio-0.9945.5689.6417.34Price / Sales5.85263.311,253.2278.66Price / CashN/A192.9043.8235.97Price / Book0.613.965.324.79Net Income-$72.73M-$41.02M$122.69M$225.00M7 Day Performance-10.06%-1.74%-0.16%1.52%1 Month Performance44.66%0.53%3.75%4.68%1 Year Performance-46.21%-1.69%27.41%20.89% DBV Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DBVTDBV Technologies3.8767 of 5 stars$4.47-5.5%$22.50+403.4%-48.0%$102.23M$15.73M-0.9980Analyst ForecastShort Interest ↓ABVXABIVAX Société Anonyme2.2794 of 5 stars$6.63+3.9%$38.67+483.2%-46.5%$420.00MN/A0.0061Short Interest ↑PRTCPureTech Health1.8712 of 5 stars$17.33-1.5%$45.00+159.7%-24.8%$414.92M$3.33M0.00100Short Interest ↑High Trading VolumeKMDAKamada4.0947 of 5 stars$7.21-2.7%$14.50+101.1%+27.6%$414.43M$158.38M25.75360Short Interest ↑CYRXCryoport3.3617 of 5 stars$8.37-1.6%$12.29+46.8%-47.6%$413.73M$233.26M-2.481,170Analyst ForecastShort Interest ↓News CoverageATXSAstria Therapeutics1.4889 of 5 stars$7.33-1.6%$25.60+249.2%-0.8%$413.66MN/A-3.5130Short Interest ↑Positive NewsALLOAllogene Therapeutics2.6252 of 5 stars$1.94-5.8%$9.73+401.7%-42.2%$406.76M$43,000.00-1.24310Positive NewsAKBAAkebia Therapeutics3.8984 of 5 stars$1.86+6.3%$7.50+303.2%+45.8%$405.82M$169.88M-8.09430Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageCDXCChromaDex4.5523 of 5 stars$5.26-0.2%$8.00+52.1%+315.4%$401.78M$91.67M526.53120Analyst DowngradeShort Interest ↑TERNTerns Pharmaceuticals4.2342 of 5 stars$4.73-5.6%$18.30+286.9%-20.8%$401.76M$1M-4.0140KODKodiak Sciences3.7215 of 5 stars$7.54-9.4%$8.00+6.1%+120.6%$396.79MN/A-2.0790Short Interest ↑Positive NewsGap Down Related Companies and Tools Related Companies ABIVAX Société Anonyme Alternatives PureTech Health Alternatives Kamada Alternatives Cryoport Alternatives Astria Therapeutics Alternatives Allogene Therapeutics Alternatives Akebia Therapeutics Alternatives ChromaDex Alternatives Terns Pharmaceuticals Alternatives Kodiak Sciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DBVT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DBVT Stock Alerts